Results 11 to 20 of about 17,990 (185)
Immunity to Visceral Leishmaniasis [PDF]
Peer ...
Ali, Nahid Ben +3 more
openaire +6 more sources
Immunobiology of visceral leishmaniasis [PDF]
Visceral leishmaniasis (VL), commonly known as kala-azar, is caused by Leishmania donovani and Leishmania infantum (Leishmania chagasi in the Americas). These Leishmania species infect macrophages throughout the viscera, and parasites are typically found in the spleen, liver, and bone marrow.
Rajiv Kumar, Susanne Nylén
openaire +4 more sources
Hyponatremia in visceral leishmaniasis [PDF]
There are few reports linking hyponatremia and visceral leishmaniasis (kala-azar). This is a study of 55 consecutive kala-azar patients and 20 normal individuals as a control group. Hyponatremia and serum hypo-osmolality were detected in 100% of kala-azar patients. High first morning urine osmolality (750.0 ± 52.0 vs.
Verde, Frederico A. Lima +5 more
openaire +5 more sources
Diagnostic advances in visceral leishmaniasis include the development of the rK39 and rK28 rapid diagnostic test. The direct agglutination test is also increasingly used, as well as conventional and real-time polymerase chain reaction, which also performs well on peripheral blood.
van Griensven, J., Diro, E.
openaire +6 more sources
Treatment of visceral leishmaniasis
The available treatment options for visceral leishmaniasis (VL) have problems relating to efficacy, adverse effects and cost, making treatment a complex issue. We review the evidence relating to the different methods of treatment in relation to - efficacy and toxicity of the drugs in different areas of the world; ability to monitor side effects, length
Diana N. J. Lockwood, EM Moore
openaire +4 more sources
Visceral Leishmaniasis in Dogs [PDF]
Background: Canine visceral leishmaniasis (CVL) is a zoonosis of variable clinical presentation, either in systemic or cutaneous form. Clinical signs include anorexia, ophthalmopathies, and chronic kidney disease. In the state of Santa Catarina, the foci are concentrated in the capital and its adjacencies, in the east side of the state.
Silveira, Nathalia Saynovich Dutra +5 more
openaire +2 more sources
Diagnosis of visceral leishmaniasis [PDF]
Leishmaniasis is a vector-borne disease with up to 350 million people at risk of infection worldwide. Among its different clinical manifestations, visceral is the most severe form. Since clinical features of visceral leishmaniasis (VL) mimic several other common diseases, accurate diagnosis is crucial as the treatment is associated with significant ...
Shyam Sundar +3 more
openaire +3 more sources
Presentation of AIDS with Disseminated Cutaneous and Visceral Leishmaniasis in Iran
Leishmaniasis is an infectious disease in form of visceral (VL), cutaneous (CL), and mucocutaneous (MCL) leishmaniasis. Immunocompromised patients have increased risk of Leishmania infection, especially in endemic areas for visceral leishmaniasis, where
Mohammadali Davarpanah +2 more
doaj +1 more source
A case of visceral leishmaniasis imported from Armenia
The relevance of the problem of visceral leishmaniasis is due to the severity of clinical manifestations, as well as the need for immediate etiotropic therapy.
A. L. Rossina +7 more
doaj +1 more source
Treatment of visceral leishmaniasis [PDF]
Growing antimony resistance in patients with visceral leishmaniasis (VL) over last two decades, especially in Indian subcontinent, renders this cheap and easily available drug useless for a vast majority of patients. Use of the second line drug pentamidine isethionate, a toxic drug with declining efficacy, has largely been abandoned.
openaire +4 more sources

